Home | All intervention

[RDF data]
Intervention #100421 (Drug:Omalizumab)

Resource URI: http://static.linkedct.org/resource/intervention/100421
linkedct:description Omalizumab (anti-IgE) will be given for 4 months prior to starting oral immunotherapy. The medication is given as a subcutaneous injection with dose based on total IgE levels and weight at the beginning of the study. This medication is given for a total of 10 months.
is linkedct:intervention of <http://static.linkedct.org/resource/trials/NCT00932282>
linkedct:intervention_id 100421 (xsd:int)
linkedct:intervention_name Omalizumab
linkedct:intervention_type Drug
rdfs:label Intervention #100421 (Drug:Omalizumab)
rdf:type linkedct:intervention